Indikationen [Bearbeiten | Quelltext bearbeiten] Diabetes mellitus Typ 2 [Bearbeiten | Quelltext bearbeiten] Der primre Einsatzbereich der Inkretinmimetika ist die Therapie des Diabetes mellitus Typ 2
Call (303) 999-9999 or complete a Free Case Evaluation form
Subcutaneous injections remain the most common route of administration
Patients who arrive at a new dose already well-hydrated and fiber-sufficient handle the transition significantly better than those who try to adjust after constipation has set in
Common Side Effects Nausea, vomiting, diarrhea, constipation, abdominal pain, headache, and fatigue
Some people alternate between the two medications over time, using semaglutide for maintenance and tirzepatide for periods when they need additional weight loss